Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129040) titled 'Exploring the Mechanism by which Resistin Inhibits Osteoarthritis through Alleviating Mitochondrial Damage Based on VDAC1 Palmitoylation Modification' on July 29.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou,China
Condition:
Osteoarthritis
Intervention:
Normal group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-01
Target Sample Size: Normal group:30;OA group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.c...